Multiple endocrine neoplasia type 2 laboratory findings: Difference between revisions
No edit summary |
|||
Line 17: | Line 17: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Urinalysis]]''' | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Urinalysis]]''' | ||
| style="background: #B8B8B8; padding: 5px;"| Elevated [[norepinephrine]]<br>Elevated [[metanephrine]]<br>Elevated [[vanillylmandelic acid]] | | style="background: #B8B8B8; padding: 5px;"| Elevated [[norepinephrine]]<br>Elevated [[metanephrine]]<br>Elevated [[vanillylmandelic acid]] | ||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" colspan="2"|<small>Adapted from Marquard J, Eng C. Multiple Endocrine Neoplasia Type 2. 1999 Sep 27 [Updated 2015 Jun 25]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1257/<ref>{{Cite journal| author = [[Jessica Marquard]] & [[Charis Eng]] | |||
| title = Multiple Endocrine Neoplasia Type 2 | |||
| year = 1993 | |||
| month = | |||
| pmid = 020301434 | |||
}}</ref> | |||
|} | |||
|} | |} | ||
Revision as of 01:25, 29 September 2015
Multiple endocrine neoplasia type 2 Microchapters |
Differentiating Multiple endocrine neoplasia type 2 from other Diseases |
---|
Diagnosis |
Treatment |
Multiple endocrine neoplasia type 2 laboratory findings On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 laboratory findings |
FDA on Multiple endocrine neoplasia type 2 laboratory findings |
CDC on Multiple endocrine neoplasia type 2 laboratory findings |
Multiple endocrine neoplasia type 2 laboratory findings in the news |
Blogs on Multiple endocrine neoplasia type 2 laboratory findings |
Directions to Hospitals Treating Multiple endocrine neoplasia type 2 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Laboratory findings consistent with the diagnosis of multiple endocrine neoplasia type 2 include hypercalcemia, hypophosphatemia, elevated parathyroid hormone and elevated norepinephrine.
Laboratory Tests
- Some of the laboratory findings of multiple endocrine neoplasia type 2 is tabulated below.
Test | Findings |
---|---|
Metabolic | Hypophosphatemia Hypercalcemia Elevated calcitonin Elevated epinephrine Elevated norepinephrine Elevated metanephrine Elevated vanillylmandelic acid Elevated parathyroid hormone Elevated pentagastrin |
Urinalysis | Elevated norepinephrine Elevated metanephrine Elevated vanillylmandelic acid |
Adapted from Marquard J, Eng C. Multiple Endocrine Neoplasia Type 2. 1999 Sep 27 [Updated 2015 Jun 25]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1257/[1] |
|}
References
|